| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/23/2008 | EP1912654A2 Methods for selectively treating cox-2 mediated disorders by administering gamma-tocopherol |
| 04/23/2008 | EP1912635A2 Use of chk2 kinase inhibitors for cancer treatment |
| 04/23/2008 | EP1912513A2 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166744A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/23/2008 | CN101166743A Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha] imidazole-3-sulfonic acid |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101166528A Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (PEG2) |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164610A Blood-circulation and removing blood stasis ointment |
| 04/23/2008 | CN101164604A Traditional Chinese medicine for treating arthrosis and preparing method thereof |
| 04/23/2008 | CN101164602A Traditional Chinese medicine for curing rheumatism |
| 04/23/2008 | CN101164591A Wind-expelling dampness-removing medicinal composition and preparation method and use thereof |
| 04/23/2008 | CN101164558A Clot-dispersing pain-relieving medicinal composition and preparation method and application thereof |
| 04/23/2008 | CN101164555A Method for inclusion essential oil from bupleurum Chinese |
| 04/23/2008 | CN101164538A Application of carboxyamido-triazoles compound and its salt in preparing medicine for treating painful diseases and/or inflammatory diseases |
| 04/23/2008 | CN100383523C Method for controlling quality of medicine composition for curing traumatic injury |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 04/23/2008 | CN100382842C Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 04/23/2008 | CN100382838C Chinese medicine for treating blood stagnation disease and preparation method thereof |
| 04/23/2008 | CN100382817C Collateral channels clearing arthralgia dredging prescription for treating rheumatoid arthritis and its preparing process |
| 04/23/2008 | CN100382815C Compound composition for treating arthralgia caused by wind-dampness and preparation thereof |
| 04/23/2008 | CN100382809C Medicinal wine for traumatic injury and its preparation method |
| 04/23/2008 | CN100382781C Method for preparing bath powder of Tibet medicine and its quality control method |
| 04/22/2008 | US7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361742 Methods and materials for treating inflammatory conditions |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 04/22/2008 | US7361660 Chemical compounds |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361358 Treating a non-spasm caused pain with botulinum toxin |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2321687C Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 04/22/2008 | CA2265993C Novel antimicrobial cosmetic compositions |
| 04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/22/2008 | CA2129542C Pharmaceutical preparation based on rhamnolipid |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008045663A2 Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents |
| 04/17/2008 | WO2008045558A2 Benzothiadiazine compounds and their use |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008044785A1 Material for improvement of cerebral blood flow, and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044331A1 Solid preparation comprising ibuprofen and tranexamic acid |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043570A1 Interferon type i supporting compounds |
| 04/17/2008 | WO2008019306A3 Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007144493A3 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090910 Methods for treatment of nocturia |
| 04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090839 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 04/17/2008 | US20080090838 N-Hydroxyamide Derivatives and Use Thereof |
| 04/17/2008 | US20080090836 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090810 Thiophene compounds |
| 04/17/2008 | US20080090809 Pyrazole compounds |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/17/2008 | US20080090788 Chemical Compounds |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089956 Nitric oxide in treatment of inflammation |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089941 Fucoidan compositions and methods |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089885 Anti-cd20 antibodies and methods of use |
| 04/17/2008 | US20080089881 Using nicotinic acid receptor (HM74) as diagnostic and evaluative tool in detection of psoraisis, ulcerative colitis, multiple sclerosis, irratable bowel and/or , crohn's diseases |
| 04/17/2008 | US20080089845 optimizing therapeutic efficacy for treatment of anxiety, depression, pain, or a metabolic disorder by increasing or decreasing a dose of a fatty amide ( oleoylethanolamide or palmitoylethanolamide) hydrolase inhibitor according to a patient's fatty amide levels by administering a carbamate derivative |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911494A2 Use of oligosaccharides to stimulate beta-endorphin production |
| 04/16/2008 | EP1911448A2 Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/16/2008 | EP1910525A1 Modulation of sphingosine kinase signalling |